Alembic Pharma
-
Alembic Pharma’s JV Aleor Dermaceuticals gets US FDA nod for Testosterone Gel
Testosterone Gel is indicated for replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous…
Read More » -
Alembic’s associate Rhizen’s cancer drug Umbralisib gets US FDA nod
The price of the drug in the US will be close to $16,000 for one month for a patient Drug…
Read More » -
Alembic Pharma gets five observations from US FDA for Gujarat facility
The inspection was conducted at the Karkhadi new injectable facility from January 29 to February 5, 2021 Alembic Pharmaceuticals said the…
Read More » -
Alembic Pharma gets US FDA nod for low blood pressure treatment drug
Midodrine Hydrochloride tablets are indicated for patients who have symptoms of low blood pressure when standing Drug firm Alembic Pharmaceuticals…
Read More » -
Alembic Pharma posts Rs 293 crore net profit in Q3
The consolidated revenue from operations of the company stood at Rs 1,314.33 crore for the quarter under consideration Alembic Pharmaceuticals…
Read More » -
Alembic Pharma gets US FDA nod for bipolar disorder treatment drug
Asenapine is an antipsychotic drug indicated for bipolar I disorder as adjunctive treatment to lithium or valproate in adults Alembic…
Read More » -
Rhizen Pharma gets US FDA approval COVID-19 drug trials
The initial study would evaluate single ascending doses of the RP7214 in healthy volunteers Rhizen Pharmaceuticals, an associate company of…
Read More » -
Alembic Pharma gets US FDA nod for elevated intraocular pressure drug
The product is indicated in the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma Drug…
Read More » -
Alembic Pharma gets US FDA nod for cholesterol lowering drug
The drugs are available in the strengths of 67 mg, 134 mg and 200 mg Alembic Pharma has received approval…
Read More » -
Alembic Pharma arm inks pact with Curon
Drug firm Alembic Pharma said its associate company, Rhizen Pharmaceuticals, has entered an exclusive license agreement with Curon Biopharmaceutical for…
Read More »